Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): ARP110101028
Who filed: Fundación Grupo Efecto Positivo
Country: Argentina
Opposition type: Pre-Grant
Opposition status: Refused
Date: 20-12-2021
Patent type: Molecules

Click within the document, or manually enter the page number below

Fundación Grupo Efecto Positivo opposition, Remdesivir (GS-5734), (AR102468)

Countries: Argentina Date: 2021
Fundación Grupo Efecto Positivo opposition, Lenacapavir, (AR109364A1)

Countries: Argentina Date: 2022
Fundación Grupo Efecto Positivo opposition, Tenofovir Alafenamide Fumarate , (P2012103681 (AR088109A1) )

Countries: Argentina Date: 2020
Fundación Grupo Efecto Positivo opposition, Lenacapavir, (AR118856 )

Countries: Argentina Date: 2022
Fundación Grupo Efecto Positivo opposition, Islatravir , (AR107596 (WO2017/139519) )

Countries: Argentina Date: 2020
Fundación Grupo Efecto Positivo opposition, Dolutegravir pediatric combination, (P20210101732 (AR122720A1))

Countries: Argentina Date: 2025
Fundación Grupo Efecto Positivo opposition, Tenofovir 300mg+ Emtricitabina 200mg (TDF+FTC), (n/a)

Countries: Argentina Date: 2015
Fundación Grupo Efecto Positivo (FGEP) opposition, Dolutegravir pediatric dispersible tablet, (P20210101730 (AR122718A1) )

Countries: Argentina Date: 2025
Fundación Grupo Efecto Positivo (FGEP) opposition, Cabotegravir/rilpirivine, ( P20180102032 (AR112282A1))

Countries: Argentina Date: 2026
Fundación Grupo Efecto Positivo (FGEP) opposition, Dolutegravir/Rilpivirine, (AR112213A1 (P20180101799) )

Countries: Argentina Date: 2025

Fundación Grupo Efecto Positivo Opposition, Doravirine (Nnrti), (Arp110101028)